Logo image of ARTV

ARTIVA BIOTHERAPEUTICS INC (ARTV) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:ARTV - US04317A1079 - Common Stock

4.42 USD
-0.04 (-0.9%)
Last: 1/16/2026, 8:00:01 PM
4.37 USD
-0.05 (-1.13%)
Pre-Market: 1/20/2026, 4:00:05 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ARTV revenue by date.ARTV revenue by date.
4.931M
146.30%
33.492M
579.21%
251K
-99.25%

-100.00%
4.427M55.573M
1,155.32%
149.71M
169.39%
335.9M
124.37%
539.18M
60.52%
661.18M
22.63%
EBITDA
YoY % growth
ARTV ebitda by date.ARTV ebitda by date.
-58.671M
-10.65%
-28.405M
51.59%
-64.851M
-128.31%
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ARTV ebit by date.ARTV ebit by date.
-59.829M
-12.31%
-30.671M
48.74%
-67.282M
-119.37%
-92.449M
-37.41%
-101.492M
-9.78%
-126.899M
-25.03%
-148.192M
-16.78%
-153.072M
-3.29%
-106.929M
30.14%
70.89M
166.30%
253.47M
257.55%
459M
81.09%
Operating Margin
ARTV operating margin by date.ARTV operating margin by date.
-1,213.32%-91.58%-26,805.58%N/AN/AN/A-3,347.45%-275.44%-71.42%21.10%47.01%69.42%
EPS
YoY % growth
ARTV eps by date.ARTV eps by date.
N/AN/AN/A-3.47
35.88%
-3.41
1.76%
-2.07
39.34%
-3.16
-52.71%
-2.78
11.94%
-0.86
69.23%
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28
EPS
Q2Q % growth
-0.84
-27.71%
-0.91
-9.37%
-0.86
0.58%
-0.85
3.10%
-0.90
-6.49%
-0.83
9.10%
-0.70
19.22%
-0.73
14.59%
-0.78
12.61%
-0.84
-2.35%
-0.89
-27.01%
-0.93
-28.01%
Revenue
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-23.702M
-29.75%
-24.48M
-10.41%
-25.628M
-12.35%
-27.043M
-18.11%
-28.441M
-20.00%
N/AN/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.88
4.86%
-0.890.010.83%
Q2 2025
Q2Q % growth
-0.87
96.05%
-0.82-0.05-5.74%
Q1 2025
Q2Q % growth
-0.83 -0.72-0.11-14.53%
Q4 2024
Q2Q % growth
-0.66 -0.770.1114.30%
Q3 2024
Q2Q % growth
-0.93 -0.930.010.71%
Q2 2024
Q2Q % growth
-22.00 -4.49-17.51-390.47%
ARTV Yearly EPS VS EstimatesARTV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 -1 -2 -3 -4 -5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth

-100.00%
%
Q4 2024
Q2Q % growth

-100.00%
59.497K-59.497K-100.00%
Q2 2024
Q2Q % growth
76.5K-76.5K-100.00%
ARTV Yearly Revenue VS EstimatesARTV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2028 2029 2030 2031 2032 2033 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 10.26% 0% 2.67%
RevenueN/A N/A N/A N/A